Ribavirin can be reduced from 800mg to 400mg in hepatitis C patients with genotype 3

Source: Inpharma, Volume 1, Number 1647, 2008-07-19 , pp. 9-9(1)

Publisher: Adis International

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

Keywords: Hepatitis-C, treatment; Peginterferon-alfa-2a, therapeutic use; Pharmacogenetics; Ribavirin, therapeutic use

Document Type: Research article

The full text electronic article is available for purchase. You will be able to download the full text electronic article after payment.

$37.95 plus tax

 

OR

Back to top

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A